As of 2024-12-12, the Relative Valuation of Enzymatica AB (publ) (ENZY.ST) is (5.01) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 1.73 SEK, the upside of Enzymatica AB (publ) based on Relative Valuation is -389.8%.
The range of the Relative Valuation is (4.41) - (4.96) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.3x - 30.6x | 23.1x |
| Forward P/E multiples | 19.9x - 22.3x | 22.0x |
| Fair Price | (4.41) - (4.96) | (5.01) |
| Upside | -355.2% - -386.5% | -389.8% |
| Date | P/E |
| 2024-11-29 | -8.01 |
| 2024-11-28 | -8.10 |
| 2024-11-27 | -7.87 |
| 2024-11-26 | -7.96 |
| 2024-11-25 | -7.96 |
| 2024-11-22 | -8.10 |
| 2024-11-21 | -7.83 |
| 2024-11-20 | -8.37 |
| 2024-11-19 | -8.19 |
| 2024-11-18 | -7.87 |
| 2024-11-15 | -8.05 |
| 2024-11-14 | -8.32 |
| 2024-11-13 | -8.23 |
| 2024-11-12 | -8.37 |
| 2024-11-11 | -8.55 |
| 2024-11-08 | -8.05 |
| 2024-11-07 | -8.10 |
| 2024-11-06 | -8.05 |
| 2024-11-05 | -8.10 |
| 2024-11-04 | -8.10 |
| 2024-11-01 | -7.78 |
| 2024-10-31 | -7.78 |
| 2024-10-30 | -7.83 |
| 2024-10-29 | -7.96 |
| 2024-10-28 | -7.96 |
| 2024-10-25 | -8.01 |
| 2024-10-24 | -8.10 |
| 2024-10-23 | -8.32 |
| 2024-10-22 | -8.50 |
| 2024-10-21 | -8.55 |
| 2024-10-18 | -8.14 |
| 2024-10-17 | -8.28 |
| 2024-10-16 | -8.23 |
| 2024-10-15 | -8.28 |
| 2024-10-14 | -8.55 |
| 2024-10-11 | -8.55 |
| 2024-10-10 | -8.19 |
| 2024-10-09 | -8.37 |
| 2024-10-08 | -8.64 |
| 2024-10-07 | -8.59 |
| 2024-10-04 | -8.55 |
| 2024-10-03 | -8.73 |
| 2024-10-02 | -8.86 |
| 2024-10-01 | -8.86 |
| 2024-09-30 | -8.59 |
| 2024-09-27 | -9.00 |
| 2024-09-26 | -9.27 |
| 2024-09-25 | -8.91 |
| 2024-09-24 | -9.90 |
| 2024-09-23 | -10.35 |